Investing.com - Financial Markets Worldwide

Maxigen Biotech Inc (1783)

Taiwan
Currency in TWD
44.05
+0.05(+0.11%)
Closed·
1783 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
1783 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
44.0044.85
52 wk Range
35.5555.00
Key Statistics
Edit
Bid/Ask
36.40 / 36.50
Prev. Close
43
Open
44.85
Day's Range
44-44.85
52 wk Range
35.55-55
Volume
44.53K
Average Volume (3m)
82.68K
1-Year Change
-2.98%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1783 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Impressive gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Maxigen Biotech Inc Company Profile

Maxigen Biotech Inc. researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally. It operates through two segments, Biomedical Products and Consumer Products. The company offers biomedical materials, such as collagen and bone materials; beauty care products; and medical devices for ophthalmology, otolaryngology, dental, surgical, orthopedics, and medical aesthetics, as well as engages in collagen purification activities. It also provides ophthalmic viscoelastic under the PreviscAid, ViscAid, and BiVisc brands; intra-articular injections under the ArtiBest and ArtiAid brands; synthetic bone grafts under the BestAid, GingivAid, FormaGraft, and Foramic brands; and dermal filler injections under the Formaderm brand. In addition, the company offers collagen based regenerative matrixes comprising HealiAid, a collagen wound dressing; NasoAid, an intranasal splint; and FormaAid, a collagen membrane. Maxigen Biotech Inc. was incorporated in 1998 and is headquartered in Taoyuan City, Taiwan.

Industry
Personal & Household Products & Services
Sector
Consumer Non-Cyclicals
0
Market
Taiwan

Compare 1783 to Peers and Sector

Metrics to compare
1783
Peers
Sector
Relationship
P/E Ratio
18.9x−25.0x−0.5x
PEG Ratio
0.490.020.00
Price/Book
2.7x2.8x2.6x
Price / LTM Sales
5.4x30.9x3.1x
Upside (Analyst Target)
-0.0%45.7%
Fair Value Upside
Unlock−13.5%5.7%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.33%
Dividend Yield
2.24%
Industry Median 4.41%
Annualised payout
1.00
Paid annually
5-Years Growth
+4.21%
Growth Streak
Unlock

Earnings

Latest Release
May 01, 2025
EPS / Forecast
0.52 / --
Revenue / Forecast
177.18M / --
EPS Revisions
a
a
Unlock
Last 90 days

1783 Income Statement

FAQ

What Stock Exchange Does MBI Trade On?

MBI is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for MBI?

The stock symbol for MBI is "1783."

What Is the MBI Market Cap?

As of today, MBI market cap is 4.00B.

What Is MBI's Earnings Per Share (TTM)?

The MBI EPS (TTM) is 2.33.

From a Technical Analysis Perspective, Is 1783 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has MBI Stock Split?

MBI has split 3 times.

How Many Employees Does MBI Have?

MBI has 0 employees.

What is the current trading status of MBI (1783)?

As of 11 Jul 2025, MBI (1783) is trading at a price of 44.05, with a previous close of 43.00. The stock has fluctuated within a day range of 44.00 to 44.85, while its 52-week range spans from 35.55 to 55.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.